291 related articles for article (PubMed ID: 24192454)
1. Curcumin amorphous solid dispersions: the influence of intra and intermolecular bonding on physical stability.
Wegiel LA; Zhao Y; Mauer LJ; Edgar KJ; Taylor LS
Pharm Dev Technol; 2014 Dec; 19(8):976-86. PubMed ID: 24192454
[TBL] [Abstract][Full Text] [Related]
2. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-Impact of different polymers.
Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
J Pharm Sci; 2013 Jan; 102(1):171-84. PubMed ID: 23132686
[TBL] [Abstract][Full Text] [Related]
3. Mid-infrared spectroscopy as a polymer selection tool for formulating amorphous solid dispersions.
Wegiel LA; Mauer LJ; Edgar KJ; Taylor LS
J Pharm Pharmacol; 2014 Feb; 66(2):244-55. PubMed ID: 24433425
[TBL] [Abstract][Full Text] [Related]
4. Advantages of introducing an effective crystalline inhibitor in curcumin amorphous solid dispersions formulated by Eudragit E100.
Fan N; Li J; Li J
J Pharm Pharmacol; 2021 Mar; 73(2):185-192. PubMed ID: 33793808
[TBL] [Abstract][Full Text] [Related]
5. Small scale screening to determine the ability of different polymers to inhibit drug crystallization upon rapid solvent evaporation.
Van Eerdenbrugh B; Taylor LS
Mol Pharm; 2010 Aug; 7(4):1328-37. PubMed ID: 20536263
[TBL] [Abstract][Full Text] [Related]
6. Investigation into Intermolecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole.
Sarpal K; Tower CW; Munson EJ
Mol Pharm; 2020 Mar; 17(3):787-801. PubMed ID: 31860316
[TBL] [Abstract][Full Text] [Related]
7. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine.
Konno H; Taylor LS
J Pharm Sci; 2006 Dec; 95(12):2692-705. PubMed ID: 16892209
[TBL] [Abstract][Full Text] [Related]
8. Ability of different polymers to inhibit the crystallization of amorphous felodipine in the presence of moisture.
Konno H; Taylor LS
Pharm Res; 2008 Apr; 25(4):969-78. PubMed ID: 17520180
[TBL] [Abstract][Full Text] [Related]
9. The role of drug-polymer hydrogen bonding interactions on the molecular mobility and physical stability of nifedipine solid dispersions.
Kothari K; Ragoonanan V; Suryanarayanan R
Mol Pharm; 2015 Jan; 12(1):162-70. PubMed ID: 25426538
[TBL] [Abstract][Full Text] [Related]
10. Investigation of drug-excipient interactions in lapatinib amorphous solid dispersions using solid-state NMR spectroscopy.
Song Y; Yang X; Chen X; Nie H; Byrn S; Lubach JW
Mol Pharm; 2015 Mar; 12(3):857-66. PubMed ID: 25585133
[TBL] [Abstract][Full Text] [Related]
11. Impact of HPMC on inhibiting crystallization and improving permeability of curcumin amorphous solid dispersions.
Fan N; He Z; Ma P; Wang X; Li C; Sun J; Sun Y; Li J
Carbohydr Polym; 2018 Feb; 181():543-550. PubMed ID: 29254005
[TBL] [Abstract][Full Text] [Related]
12. Phase behavior, intermolecular interaction, and solid state characterization of amorphous solid dispersion of Febuxostat.
Kini A; Patel SB
Pharm Dev Technol; 2017 Feb; 22(1):45-57. PubMed ID: 26853838
[TBL] [Abstract][Full Text] [Related]
13. Effect of Drug-Polymer Interactions through Hypromellose Acetate Succinate Substituents on the Physical Stability on Solid Dispersions Studied by Fourier-Transform Infrared and Solid-State Nuclear Magnetic Resonance.
Ishizuka Y; Ueda K; Okada H; Takeda J; Karashima M; Yazawa K; Higashi K; Kawakami K; Ikeda Y; Moribe K
Mol Pharm; 2019 Jun; 16(6):2785-2794. PubMed ID: 31045376
[TBL] [Abstract][Full Text] [Related]
14. Role of the Strength of Drug-Polymer Interactions on the Molecular Mobility and Crystallization Inhibition in Ketoconazole Solid Dispersions.
Mistry P; Mohapatra S; Gopinath T; Vogt FG; Suryanarayanan R
Mol Pharm; 2015 Sep; 12(9):3339-50. PubMed ID: 26070543
[TBL] [Abstract][Full Text] [Related]
15. Investigation of griseofulvin and hydroxypropylmethyl cellulose acetate succinate miscibility in ball milled solid dispersions.
Al-Obaidi H; Lawrence MJ; Al-Saden N; Ke P
Int J Pharm; 2013 Feb; 443(1-2):95-102. PubMed ID: 23299082
[TBL] [Abstract][Full Text] [Related]
16. Investigation for the amorphous state of ER-34122, a dual 5-lipoxygenase/cyclooxygenase inhibitor with poor aqueous solubility, in HPMC solid dispersion prepared by the solvent evaporation method.
Kushida I; Gotoda M
Drug Dev Ind Pharm; 2013 Oct; 39(10):1582-8. PubMed ID: 22519663
[TBL] [Abstract][Full Text] [Related]
17. Amorphous stabilization and dissolution enhancement of amorphous ternary solid dispersions: combination of polymers showing drug-polymer interaction for synergistic effects.
Prasad D; Chauhan H; Atef E
J Pharm Sci; 2014 Nov; 103(11):3511-3523. PubMed ID: 25196860
[TBL] [Abstract][Full Text] [Related]
18. Solvent-shift strategy to identify suitable polymers to inhibit humidity-induced solid-state crystallization of lacidipine amorphous solid dispersions.
Sun M; Wu C; Fu Q; Di D; Kuang X; Wang C; He Z; Wang J; Sun J
Int J Pharm; 2016 Apr; 503(1-2):238-46. PubMed ID: 26869398
[TBL] [Abstract][Full Text] [Related]
19. Effect of Temperature and Moisture on the Physical Stability of Binary and Ternary Amorphous Solid Dispersions of Celecoxib.
Xie T; Taylor LS
J Pharm Sci; 2017 Jan; 106(1):100-110. PubMed ID: 27476771
[TBL] [Abstract][Full Text] [Related]
20. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
Jackson MJ; Kestur US; Hussain MA; Taylor LS
Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]